Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Plos One|April 19, 2018
Data quality of whole genome bisulfite sequencing on Illumina platformsAmanda Raine, Ulrika Liljedahl, Jessica NordlundCardiovascular Toxicology|July 28, 2005
Hypertension and SNP genotyping in antihypertensive treatmentLisa Kurland, Ulrika Liljedahl, Lars LindGenomics|November 29, 2005
Tag/anti-tag liquid-phase primer extension array: a flexible and versatile genotyping platformJing-Guang Li, Ulrika Liljedahl, Chew-Kiat HengBMC Biotechnology|October 27, 2004
Detecting imbalanced expression of SNP alleles by minisequencing on microarraysUlrika Liljedahl, Mona Fredriksson, Andreas Dahlgren, et al.Nucleic Acids Research|October 25, 2003
Quantitative evaluation by minisequencing and microarrays reveals accurate multiplexed SNP genotyping of whole genome amplified DNALovisa Lovmar, Mona Fredriksson, Ulrika Liljedahl, et al.BMC Cardiovascular Disorders|September 30, 2004
Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatmentUlrika Liljedahl, Lars Lind, Lisa Kurland, et al.Science Signaling|February 11, 2010
SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptorBita Sehat, Ali Tofigh, Yingbo Lin, et al.Journal of Hypertension|December 23, 2004
Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatmentUlrika Liljedahl, Thomas Kahan, Karin Malmqvist, et al.American Journal of Hypertension|January 1, 2004
Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trialLisa Kurland, Ulrika Liljedahl, Julia Karlsson, et al.American Journal of Hypertension|May 10, 2008
The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) TrialLisa Kurland, Pär Hallberg, Håkan Melhus, et al.Pageof 4